Transient ischemic attack

Introduction

Transient ischemic attack (TIA) is a temporary episode of neurological dysfunction resulting from brief cerebral ischemia without acute infarction. It is considered a warning sign for potential future strokes, making prompt recognition and management crucial. Early intervention can significantly reduce the risk of permanent neurological damage.

Definition and Classification

Definition of Transient Ischemic Attack

A TIA is defined as a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, without evidence of acute infarction on neuroimaging. Symptoms typically resolve within minutes to hours, often within 24 hours.

Classification Based on Duration

• Traditional definition: Symptoms lasting less than 24 hours.
• Tissue-based definition: Any transient neurological deficit without infarction on MRI, regardless of duration.

Types of TIA

• Carotid territory TIA: Involves the anterior circulation, affecting motor, sensory, or visual pathways.
• Vertebrobasilar territory TIA: Involves the posterior circulation, leading to dizziness, vertigo, ataxia, or visual disturbances.

Epidemiology

• Incidence and prevalence globally: TIA affects approximately 200,000 to 500,000 people annually in the United States, with similar prevalence in other developed countries. Rates may be higher in populations with uncontrolled vascular risk factors.
• Age, sex, and ethnic distribution: The incidence increases with age, particularly in individuals over 55 years. Men have a slightly higher risk, and certain ethnic groups, including African Americans and South Asians, demonstrate higher susceptibility.
• Risk factors and comorbidities: Hypertension, diabetes, hyperlipidemia, atrial fibrillation, smoking, and prior cardiovascular events increase the likelihood of TIA.

Etiology and Pathophysiology

• Atherosclerosis and large artery disease: Plaque formation in carotid or vertebral arteries can lead to transient cerebral ischemia due to emboli or flow restriction.
• Cardioembolism: Thrombi from the heart, particularly in atrial fibrillation or valvular heart disease, can transiently obstruct cerebral vessels.
• Small vessel (lacunar) disease: Occlusion of penetrating arterioles due to hypertension or diabetes may cause brief focal deficits.
• Other causes: Hypercoagulable states, vasculitis, arterial dissections, and rare metabolic disorders can precipitate TIA.
• Mechanisms of cerebral ischemia: TIAs result from transient reduction in cerebral blood flow, leading to temporary neuronal dysfunction without permanent tissue injury.

Clinical Features

• Focal neurological deficits: Sudden onset of weakness, numbness, or paralysis affecting one side of the body or a specific limb.
• Motor symptoms: Hemiparesis, facial droop, or difficulty with fine motor skills.
• Sensory symptoms: Numbness, tingling, or loss of sensation in a localized area.
• Speech and language disturbances: Aphasia, dysarthria, or difficulty finding words.
• Visual symptoms: Monocular vision loss, hemianopia, or blurred vision.
• Duration and pattern of symptoms: Typically lasts minutes to less than one hour; symptoms resolve completely without permanent deficits.
• Associated systemic symptoms: Occasionally, patients may report dizziness, imbalance, or headache depending on the vascular territory involved.

Diagnostic Evaluation

• Clinical assessment and history taking: Detailed history focusing on onset, duration, and nature of symptoms, as well as vascular risk factors.
• Neurological examination: Assessment for subtle deficits in motor, sensory, cranial nerve, and cerebellar function.
• Neuroimaging: CT scan to exclude hemorrhage; MRI with diffusion-weighted imaging to detect acute ischemia.
• Vascular imaging: Carotid Doppler ultrasound, CT angiography, or MR angiography to identify stenosis or occlusion.
• Cardiac evaluation: Electrocardiography, echocardiography, and Holter monitoring to detect atrial fibrillation or structural cardiac sources of emboli.
• Laboratory investigations: Blood glucose, lipid profile, coagulation studies, and inflammatory markers to identify modifiable risk factors.

Risk Stratification

• Clinical scoring systems: The ABCD2 score assesses risk of stroke following a TIA, incorporating Age, Blood pressure, Clinical features, Duration of symptoms, and Diabetes status.
• Identification of high-risk patients: Patients with high ABCD2 scores, multiple TIAs, or significant carotid stenosis are at increased risk for subsequent stroke and require urgent evaluation and management.

Treatment and Management

Acute Management

• Immediate assessment and stabilization: Ensure airway, breathing, and circulation; monitor neurological status and vital signs.
• Antiplatelet therapy: Initiation of aspirin or combination therapy with clopidogrel for non-cardioembolic TIA to prevent recurrent events.
• Anticoagulation: Indicated for patients with cardioembolic sources such as atrial fibrillation to reduce risk of thromboembolic stroke.
• Management of acute factors: Blood pressure control, glucose management, and correction of electrolyte abnormalities.

Secondary Prevention

• Lifestyle modification and risk factor control: Smoking cessation, regular physical activity, healthy diet, and weight management.
• Statins and lipid-lowering therapy: Reduce atherosclerotic plaque progression and subsequent ischemic events.
• Carotid endarterectomy or stenting: Considered in patients with significant carotid stenosis to prevent recurrent TIA or stroke.
• Long-term antithrombotic therapy: Ongoing use of antiplatelet or anticoagulant agents based on underlying etiology and risk profile.

Prognosis and Complications

• Risk of subsequent stroke: Patients who experience a TIA have a significantly increased risk of stroke, especially within the first 48 hours to 90 days following the event.
• Recurrence of TIA: Recurrent transient ischemic attacks are common, particularly in patients with uncontrolled vascular risk factors.
• Long-term functional outcomes: While TIAs typically resolve without permanent deficits, repeated events or progression to stroke can result in long-term neurological impairment and disability.

References

1. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack. Stroke. 2009;40(6):2276-2293.
2. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of patients with ischemic stroke: 2007 update. Stroke. 2007;38(5):1655-1711.
3. Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke. Stroke. 2011;42(2):517-584.
4. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. Stroke. 2011;42(1):227-276.
5. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of acute ischemic stroke. Stroke. 2013;44(3):870-947.
6. Caplan LR. Caplan’s Stroke: A Clinical Approach. 5th ed. Philadelphia: Elsevier; 2015.
7. Fisher M, et al. Stroke and Transient Ischemic Attack. In: Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia: Elsevier; 2019.
8. Johnston SC, Easton JD, Farrant M, et al. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284(22):2901-2906.
9. Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the prevention of stroke in patients with stroke or transient ischemic attack. Stroke. 2021;52:e364–e467.
10. Rothwell PM, Giles MF, Flossmann E, et al. Effect of urgent treatment of transient ischemic attack and minor stroke on early recurrent stroke (EXPRESS study). Lancet. 2007;370(9596):1432-1442.